mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for ACOT12
Gene summary
Basic gene Info.Gene symbolACOT12
Gene nameacyl-CoA thioesterase 12
SynonymsCACH-1|Cach|STARD15|THEAL
CytomapUCSC genome browser: 5q14.1
Type of geneprotein-coding
RefGenesNM_130767.2,
DescriptionSTART domain-containing protein 15StAR-related lipid transfer (START) domain containing 15acyl-CoA thioester hydrolase 12acyl-coenzyme A thioesterase 12cytoplasmic acetyl-CoA hydrolase 1cytosolic acetyl-CoA hydrolasehCACH-1
Modification date20141207
dbXrefs MIM : 614315
HGNC : HGNC
Ensembl : ENSG00000172497
HPRD : 16680
Vega : OTTHUMG00000131305
ProteinUniProt: Q8WYK0
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_ACOT12
BioGPS: 134526
PathwayNCI Pathway Interaction Database: ACOT12
KEGG: ACOT12
REACTOME: ACOT12
Pathway Commons: ACOT12
ContextiHOP: ACOT12
ligand binding site mutation search in PubMed: ACOT12
UCL Cancer Institute: ACOT12
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for ACOT12

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
S84E86DHNSC1
S84S84NSTAD1
I281R279CUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for ACOT12
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
S84S84N-1.2330129
I281R279C-1.2151255
S84E86D-1.1618929
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for ACOT12 from PDB

Top
Differential gene expression and gene-gene network for ACOT12
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of ACOT12 and the right PPI network was created from samples without mutations in the LBS of ACOT12. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for ACOT12
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for ACOT12
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of ACOT12 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
COACOENZYME A3b7kBI281
COACOENZYME A3b7kCS84
COACOENZYME A3b7kAS84 I281


Top
Conservation information for LBS of ACOT12
Multiple alignments for Q8WYK0 in multiple species
LBSAA sequence# speciesSpecies
A54ISCVTASMDDI2Mus musculus, Rattus norvegicus
A54VSCVTASVDDI1Homo sapiens
F235VDMFKFRGPST3Homo sapiens, Mus musculus, Rattus norvegicus
F81KVTRAFSTSME3Homo sapiens, Mus musculus, Rattus norvegicus
G202HGNTFGGQIMA3Homo sapiens, Mus musculus, Rattus norvegicus
G237MFKFRGPSTVG3Homo sapiens, Mus musculus, Rattus norvegicus
I205TFGGQIMAWME3Homo sapiens, Mus musculus, Rattus norvegicus
I281GQGRHINSAFL2Mus musculus, Rattus norvegicus
I281GRGRHINSAFL1Homo sapiens
K234SVDMFKFRGPS3Homo sapiens, Mus musculus, Rattus norvegicus
L148RRKVRLQHENT2Mus musculus, Rattus norvegicus
L148RRKVRLQHEDT1Homo sapiens
P238FKFRGPSTVGD3Homo sapiens, Mus musculus, Rattus norvegicus
R144LASERRKVRLQ2Mus musculus, Rattus norvegicus
R144LAAERRKVRLQ1Homo sapiens
R236DMFKFRGPSTV3Homo sapiens, Mus musculus, Rattus norvegicus
S239KFRGPSTVGDR3Homo sapiens, Mus musculus, Rattus norvegicus
S55SCVTASMDDIL2Mus musculus, Rattus norvegicus
S55SCVTASVDDIQ1Homo sapiens
S82VTRAFSTSMEI3Homo sapiens, Mus musculus, Rattus norvegicus
S84RAFSTSMEISI3Homo sapiens, Mus musculus, Rattus norvegicus
T110SVAFSTFVAKP1Homo sapiens
T110CVAFSTFVAKP1Mus musculus
T110CVAFSTFVVKP1Rattus norvegicus
T200NHHGNTFGGQI3Homo sapiens, Mus musculus, Rattus norvegicus
T53GISCVTASMDD2Mus musculus, Rattus norvegicus
T53GVSCVTASVDD1Homo sapiens
T83TRAFSTSMEIS3Homo sapiens, Mus musculus, Rattus norvegicus
V112AFSTFVAKPVG2Homo sapiens, Mus musculus
V112AFSTFVVKPLG1Rattus norvegicus
V52AGISCVTASMD2Mus musculus, Rattus norvegicus
V52AGVSCVTASVD1Homo sapiens


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas